T1	Participants 57 96	locally advanced nasopharyngeal cancer:
T2	Participants 152 165	single centre
T3	Participants 333 392	patients with locoregionally advanced nasopharyngeal cancer
T4	Participants 421 564	From August 1999 to December 2004, 206 patients with locally advanced NPC were randomised with 101 to cisplatin arm and 105 to carboplatin arm.
T5	Participants 1730 1762	locoregional advanced stage NPC.
